文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

机器学习和小鼠模型解释临床脓毒症试验失败的原因

Machine learning and murine models explain failures of clinical sepsis trials.
PubMed 文献 · J Trauma Acute Care Surg · 2022-05-20
一句话结论在铜绿假单胞菌肺炎脓毒症小鼠模型中,氢化可的松、抗坏血酸和硫胺素联合治疗获益极小,且对生存无影响,提示肺部脓毒症与腹腔脓毒症对HAT治疗反应不同。

背景:多项临床试验未能证实氢化可的松、抗坏血酸和硫胺素(HAT)对脓毒症的疗效,这些试验以肺部脓毒症患者为主。本研究采用铜绿假单胞菌肺炎小鼠模型(PNA),与既往腹腔脓毒症模型(CLP)直接比较,用机器学习根据早期生命体征将动物分为预测死亡组(pDie)和预测存活组(pLive),随机给予抗生素加液体(VEH)或HAT。结果显示,在PNA中HAT仅使72小时支气管肺泡灌洗液中白细胞介素1受体拮抗剂低于VEH(2.36 ng/mL vs 4.88 ng/mL,p=0.04),其余炎症细胞因子及肝肾功能标志物无显著差异;PNA小鼠未发生急性肾损伤(血尿素氮pDie 33.5 mg/dL vs pLive 27.6 mg/dL,p=0.17),HAT未显著减轻肾脏显微氧化应激(平均灰度面积pDie 16.64 vs pLive 6.88,p=0.93),且对生存无影响。结论:HAT在肺炎中获益极小,肺部脓毒症与腹腔脓毒症的炎症反应不同,不同病因的脓毒症对HAT治疗反应不同。

要点

  • 在铜绿假单胞菌肺炎脓毒症小鼠模型中,HAT对生存无影响,而既往CLP模型中HAT显示生存获益。
  • PNA中HAT仅使72小时支气管肺泡灌洗液白细胞介素1受体拮抗剂低于VEH(2.36 ng/mL vs 4.88 ng/mL,p=0.04),其余炎症细胞因子及肝肾功能标志物无显著差异。
  • PNA小鼠未发生急性肾损伤:血尿素氮pDie 33.5 mg/dL vs pLive 27.6 mg/dL,p=0.17。
  • PNA后HAT未显著减轻肾脏显微氧化应激:平均灰度面积pDie 16.64 vs pLive 6.88,p=0.93。
  • PNA维生素C水平为0.62 mg/dL(pDie HAT),低于CLP后的1.195 mg/dL。

适用人群与场景

  • 铜绿假单胞菌肺炎脓毒症小鼠模型(PNA),使用119只远交系野生型Institute of Cancer Research小鼠,预测死亡率约50%。

诊断标准与关键阈值

  • 用机器学习根据早期生命体征将动物分为预测死亡组(pDie)和预测存活组(pLive)。

处置流程与药物剂量

  • 动物随机接受抗生素加液体(VEH)或氢化可的松、抗坏血酸和硫胺素联合治疗(HAT)。

研究设计与关键结果

  • 研究类型:动物实验;样本量:119只远交系野生型Institute of Cancer Research小鼠;人群:铜绿假单胞菌肺炎脓毒症模型(PNA),预测死亡率约50%。
  • 干预与对照:抗生素加液体(VEH) vs 氢化可的松、抗坏血酸和硫胺素联合治疗(HAT)。
  • 主要终点结果:PNA中HAT对生存无影响;72小时支气管肺泡灌洗液白细胞介素1受体拮抗剂HAT组2.36 ng/mL vs VEH组4.88 ng/mL,p=0.04。
  • 关键次要终点:其余炎症细胞因子及肝肾功能标志物在PNA中HAT组与VEH组无显著差异;血尿素氮pDie组33.5 mg/dL vs pLive组27.6 mg/dL,p=0.17;肾脏显微氧化应激平均灰度面积pDie组16.64 vs pLive组6.88,p=0.93;PNA维生素C水平0.62 mg/dL(pDie HAT),低于CLP后的1.195 mg/dL。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠模型)。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为,HAT治疗在肺炎中获益极小;肺部脓毒症诱导的炎症反应与腹腔脓毒症不同;不同病因的脓毒症对HAT治疗反应不同。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Multiple clinical trials failed to demonstrate the efficacy of hydrocortisone, ascorbic acid, and thiamine (HAT) in sepsis. These trials were dominated by patients with pulmonary sepsis and have not accounted for differences in the inflammatory responses across varying etiologies of injury/illness. Hydrocortisone, ascorbic acid, and thiamine have previously revealed tremendous benefits in animal peritonitis sepsis models (cecal ligation and puncture [CLP]) in contradiction to the various clinical trials. The impact of HAT remains unclear in pulmonary sepsis. Our objective was to investigate the impact of HAT in pneumonia, consistent with the predominate etiology in the discordant clinical trials. We hypothesized that, in a pulmonary sepsis model, HAT would act synergistically to reduce end-organ dysfunction by the altering the inflammatory response, in a unique manner compared with CLP.

METHODS: Using Pseudomonas aeruginosa pneumonia, a pulmonary sepsis model (pneumonia [PNA]) was compared directly to previously investigated intra-abdominal sepsis models. Machine learning applied to early vital signs stratified animals into those predicted to die (pDie) versus predicted to live (pLive). Animals were then randomized to receive antibiotics and fluids (vehicle [VEH]) vs. HAT). Vitals, cytokines, vitamin C, and markers of liver and kidney function were assessed in the blood, bronchoalveolar lavage, and organ homogenates.

RESULTS: PNA was induced in 119 outbred wild-type Institute of Cancer Research mice (predicted mortality approximately 50%) similar to CLP. In PNA, interleukin 1 receptor antagonist in 72-hour bronchoalveolar lavage was lower with HAT (2.36 ng/mL) compared with VEH (4.88 ng/mL; p = 0.04). The remaining inflammatory cytokines and markers of liver/renal function showed no significant difference with HAT in PNA. PNA vitamin C levels were 0.62 mg/dL (pDie HAT), lower than vitamin C levels after CLP (1.195 mg/dL). Unlike CLP, PNA mice did not develop acute kidney injury (blood urea nitrogen: pDie, 33.5 mg/dL vs. pLive, 27.6 mg/dL; p = 0.17). Furthermore, following PNA, HAT did not significantly reduce microscopic renal oxidative stress (mean gray area: pDie, 16.64 vs. pLive, 6.88; p = 0.93). Unlike CLP where HAT demonstrated a survival benefit, HAT had no impact on survival in PNA.

CONCLUSION: Hydrocortisone, ascorbic acid, and thiamine therapy has minimal benefits in pneumonia. The inflammatory response induced by pulmonary sepsis is unique compared with the response during intra-abdominal sepsis. Consequently, different etiologies of sepsis respond differently to HAT therapy.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Stolarski AE, Kim J, Rop K, et al. Machine learning and murine models explain failures of clinical sepsis trials. J Trauma Acute Care Surg. 2022. PMID: 35881034. doi:10.1097/TA.0000000000003691

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。